ABBOTINDIA25,230.00

Abbott India Ltd.

· Pharma & Health
₹ CrorePeersPFIZERGLAXOIPCALABAJANTPHARMANTHEMMEDANTAGLENMARKBIOCON
Holding % of Total Shares
12 Months Ending
Q2 FY17
30/09/2016
Q3 FY17
31/12/2016
Q4 FY17
31/03/2017
Q1 FY18
30/06/2017
Q2 FY18
30/09/2017
Q3 FY18
31/12/2017
Q4 FY18
31/03/2018
Q1 FY19
30/06/2018
Q2 FY19
30/09/2018
Q3 FY19
31/12/2018
Promoter & Group74.9974.9974.9974.9974.9974.9974.9974.9974.9974.99
Latest: 2018-12-31 · 25 quarters of history · click a row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.